Skip to main content
SYNTARA LIMITED logo

SYNTARA LIMITED — Investor Relations & Filings

Ticker · SNT ISIN · AU0000312480 LEI · 52990054L6XWT345FW20 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,619 across all filing types
Latest filing 2024-02-05 Share Issue/Capital Cha…
Country AU Australia
Listing ASX SNT

About SYNTARA LIMITED

https://syntaratx.com.au/

Syntara Limited is a clinical-stage drug development company focused on the discovery and development of novel small molecule therapeutics for inflammatory and fibrotic diseases. The company specializes in the inhibition of amine oxidase enzymes, including lysyl oxidase (LOX) and semicarbazide-sensitive amine oxidase (SSAO). Its primary clinical focus is on hematological malignancies and multi-organ fibrosis. The lead drug candidate, PXS-5505, is a pan-LOX inhibitor currently being evaluated for the treatment of myelofibrosis. Additionally, the company develops treatments for skin scarring, pulmonary fibrosis, and neurodegenerative conditions. Syntara leverages its proprietary drug discovery platform to address significant unmet medical needs through targeted enzymatic inhibition, aiming to modify disease progression in complex pathological environments.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - SNT 6 pages 18.4KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an announcement by Syntara Limited regarding the application for quotation of securities on the ASX. It details the number and type of securities to be quoted, issue dates, issue prices, and issued capital following quotation. This is a formal announcement related to the listing or quotation of securities rather than a financial report, earnings release, or management discussion. The document is a regulatory announcement about capital market activity, specifically the quotation of securities, which aligns with the category for Share Issue/Capital Change filings. Therefore, the appropriate classification is 'SHA' for Share Issue/Capital Change.
2024-02-05 English
Application for quotation of securities - SNT 6 pages 18.1KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an announcement by SYNTARA LIMITED regarding the application for quotation of securities on the ASX. It details the number and type of securities to be quoted, issue dates, and issued capital following quotation. This is a formal application for listing new securities rather than a report on financial performance or management. The document is structured as an official announcement related to capital market activities, specifically the quotation of securities. This fits the category of Share Issue/Capital Change announcements, which cover new share issues and related capital changes.
2024-02-05 English
Section 708A(5)9e) Notice 1 page 124.8KB
Capital/Financing Update Classification · 95% confidence The document is a Section 708A(5)(e) Notice under the Corporations Act 2001 (Cth), which relates to the issuance of new shares without disclosure under Part 6D.2 of the Corporations Act. It references a prior shareholder approval for a share placement and confirms compliance with relevant sections of the Corporations Act. The document is short (1576 characters) and serves as a formal announcement of a capital raising event and share issuance. It does not contain financial statements or detailed financial data but rather provides regulatory disclosure about the capital raising. Therefore, it fits the category of Capital/Financing Update (CAP).
2024-02-05 English
Change of Director's Interest Notice 2 pages 239.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the nature of the interest, number of securities held before and after the change, and the nature of the transaction (participation in placement). This is a clear report of personal share transactions by a company director. The document length is 3241 characters, which is consistent with a detailed director's dealing notice rather than a full financial report or announcement. Therefore, the document fits the definition of Director's Dealing (DIRS).
2024-02-05 English
Notification of cessation of securities - SNT 4 pages 14.8KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the cessation (lapse) of certain securities (options) for Syntara Limited. It provides specifics about the securities that have ceased, the reason for cessation, and the updated issued capital following these changes. The document is a formal announcement to the ASX about changes in the company's securities, specifically the cessation of certain options. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an announcement of a change in securities status. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about securities status changes that do not fit into more specific categories like Share Issue/Capital Change or Director's Dealing. The document length is under 5,000 characters and is a formal notification to the exchange, consistent with RNS filings.
2024-02-05 English
Notification of cessation of securities - SNT 4 pages 14.8KB
Share Issue/Capital Change Classification · 95% confidence The document is an Appendix 3H form titled 'Notification of cessation of securities' from Syntara Limited. It details the lapse of performance rights securities due to conditions not being met, including specific numbers and dates. This type of announcement is related to changes in the company's issued capital, specifically the cessation of certain securities. It is not a full financial report, earnings release, or management discussion. It is a regulatory announcement about securities ceasing to exist, which fits best under the category of Share Issue/Capital Change (SHA). The document length is under 5,000 characters and contains detailed information about securities cessation, not just a brief notice or a report publication announcement. Therefore, the classification is SHA with high confidence.
2024-02-05 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.